Sunzen Group Bhd

Sunzen Group Bhd Equity

The The Equity of Sunzen Group Bhd (SUNZEN.KL) as of Nov 15, 2026 is 148.68 M MYR. In the previous year, The Equity was 139.39 M MYR — a change of 6.66% (higher).

Equity

148.68 MMYR

YoY

6.66%

Last updated:

In 2025, Sunzen Group Bhd's equity was 148.68 M MYR, a 6.66% increase from the 139.39 M MYR equity in the previous year.

The Sunzen Group Bhd Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
106.94 M MYR
Jan 1, 2019
91.37 M MYR
Jan 1, 2020
87.47 M MYR
Jan 1, 2021
118.10 M MYR
Jan 1, 2022
121.88 M MYR
Jan 1, 2023
139.59 M MYR
Jan 1, 2024
139.39 M MYR
Jan 1, 2025
148.68 M MYR
The Sunzen Group Bhd Equity history
YEAREquityYoY
148.68 MMYR+6.66%
139.39 MMYR-0.14%
139.59 MMYR+14.53%
121.88 MMYR+3.20%
118.10 MMYR+35.01%
87.47 MMYR-4.26%
91.37 MMYR-14.56%
106.94 MMYR+7.53%
99.45 MMYR+2.28%
97.23 MMYR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunzen Group Bhd Stock analysis

What does Sunzen Group Bhd do? Sunzen Biotech Bhd. generates revenue through its four business segments: manufacturing and trading of animal health products, trading and processing of crude palm oil and related products, traditional Chinese medicines and herbal health foods and beverages, and loan financing. Its products, including bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, and Bai Foong Wan, are sold via retail concept stores in Malaysia and the Ecolite online shop. The company's subsidiaries, such as Sunzen Corporation Sdn. Bhd. and Sunzen Lifesciences Sdn. Bhd., support these operations. Customers include consumers purchasing health and wellness products through physical stores and online platforms. The firm's animal health products segment focuses on feed supplements for animals, while the crude palm oil segment handles trading and processing of palm oil derivatives. Traditional Chinese medicine products like Pi Pa Gao cough syrup and Bai Foong Wan target health-conscious consumers. Loan financing through Finsource Credit (M) Sdn. Bhd. provides financial services to customers seeking credit solutions. Sunzen International Sdn. Bhd. likely manages international distribution of products, and Sunzen Lifesciences Sdn. Bhd. supports biotechnology research and development. The company's product portfolio spans health drinks, herbal remedies, and financial services, with sales driven by retail stores and online channels in Malaysia. Sunzen Group Bhd is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sunzen Group Bhd's Equity

Sunzen Group Bhd's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sunzen Group Bhd's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sunzen Group Bhd's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sunzen Group Bhd's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sunzen Group Bhd’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sunzen Group Bhd stock

The Equity of Sunzen Group Bhd is 148.68 M MYR in 2025.

The Equity of Sunzen Group Bhd changed from 139.39 M MYR to 148.68 M MYR, representing a 6.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sunzen Group Bhd since 2006 – with annual values, charts, and detailed analysis.

The Equity's MYR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sunzen Group Bhd historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Sunzen Group Bhd

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Sunzen Group Bhd